Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.62% | 0.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.62% | 0.30% | |||
| Cost of Revenue | 4.54% | -6.99% | |||
| Gross Profit | 2.20% | 2.08% | |||
| SG&A Expenses | -5.12% | 7.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.80% | 0.56% | |||
| Operating Income | 61.03% | -2.87% | |||
| Income Before Tax | -3.79% | -2.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.79% | -2.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.79% | -2.81% | |||
| EBIT | 61.03% | -2.87% | |||
| EBITDA | 60.70% | -2.86% | |||
| EPS Basic | -43.94% | -0.70% | |||
| Normalized Basic EPS | -2.48% | 0.62% | |||
| EPS Diluted | -43.45% | -1.05% | |||
| Normalized Diluted EPS | -2.48% | 0.62% | |||
| Average Basic Shares Outstanding | 3.08% | 1.84% | |||
| Average Diluted Shares Outstanding | 3.08% | 1.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.05% | -0.01% | |||